Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Praticien-chercheur
10 articles scientifiques publiés — formation continue solide
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
11
11 articles ont été cités au moins 11fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
522
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
28
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
11
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université de Versailles Saint-Quentin-en-Yvelines · Université Paris-Saclay · Institut Gustave Roussy
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Multicenter External Validation of the Deep Pelvic Endometriosis Index Magnetic Resonance Imaging Score
2023ArticleJAMA Network Open
Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae
2018ArticleOncotarget
Dynamic Magnetic Resonance Imaging and pelvic floor disorders: How and when?
2014ArticleEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Cancer · 2008
AbstractBACKGROUNDThe evaluation of residual disease (RD) after chemoradiation therapy (CRT) in stage IB2/II cervical carcinoma conventionally is based on a clinical examination and magnetic resonance imaging (MRI) performed 3 to 8 weeks after the end of treatment. Very few studies have correlated MRI and histologic findings specifically in cervix cancer. This was the objective of the current study.METHODSA retrospective review was undertaken of patients who fulfilled the following inclusion criteria: 1) stage IB2/II cervical cancer, 2) external radiotherapy (45 grays [Gy]) was given with concomitant chemotherapy followed by uterovaginal brachytherapy (15 Gy), 3) MRI studies were obtained between 3 weeks and 8 weeks after brachytherapy, and 4) completion surgery included at least a hysterectomy. Postsurgical histologic findings and MRI results were compared.RESULTSForty‐four patients who were treated between 2003 and 2006 fulfilled all inclusion criteria. Twelve patients (27%) had achieved a radiologic complete response, 16 patients (36.5%) had unclassified lesions (RD or ‘fibrosis’), and 16 patients (36.5%) had radiologic residual tumor. According to the histologic results, 19 patients (43%) had no RD, 10 patients (23%) had inframillimeter RD, 2 patients (5%) had RD that measured <1 cm, and 13 patients (29%) had RD that measured >1 cm. The sensitivity and specificity of MRI in evaluating RD were 80% and 55%, respectively.CONCLUSIONSThe current results indicated that the evaluation of RD 3 to 8 weeks after CRT with MRI is difficult, and the risk of false‐positive results is high. Another radiologic procedure or a more technologically advanced MRI technique, such as diffusion‐weighted MRI, should be evaluated. Cancer 2008. © 2008 American Cancer Society.
Journal of magnetic resonance imaging : JMRI · 2011
AbstractMagnetic resonance imaging (MRI) remains the standard modality for the local staging of gynecological malignancies but it has several limitations, particularly for lymph node staging or evaluating peritoneal carcinomatosis. Consequently, there has been a growing interest in functional imaging modalities. Based on molecular diffusion, diffusion‐weighted imaging (DWI) is a unique, noninvasive modality that provides excellent tissue contrast and was shown to improve the radiological diagnosis of malignant tumors. Using quantitative apparent diffusion coefficient (ADC) measurement of DWI provides a new tool for better distinguishing malignant tissues from benign tumors. The aim of the present review is to report on the results of DWI for the assessment of patients with gynecological malignancies. An analysis of the literature suggests that DWI studies would improve the diagnosis of cervical and endometrial tumors. It may also improve the assessment of tumor extension in patients with peritoneal carcinomatosis from gynecological malignancies. However, since the signal intensity of some cancers can range from high intensity to low intensity, a degree of uncertainty was demonstrated due to the proximity of the normal uterine myometrium and ovaries. Interestingly, there is also evidence that ADC might improve the follow‐up and monitoring of patients who receive anticancer therapies, including chemotherapy or radiation therapy. J. Magn. Reson. Imaging 2011;33:1020–1027. © 2011 Wiley‐Liss, Inc.
Neurourology and urodynamics · 2008
AbstractAimsTo assess and compare the reliability of dynamic MRI to quantify pelvic organ prolapse (POP) according to the International Continence Society (ICS) using two different reference lines, and to determine which line gives the best concordance with clinical examination.MethodsForty‐seven patients with genital prolapse underwent physical examination and dynamic MRI. Five nulliparous, symptom‐free female volunteers underwent dynamic MRI as control subjects. Two distinct observers performed the MRI measurements of POP according to the ICS using two distinct reference lines: the mid‐pubic line and a new one, the perineal line that provides a better match with the hymen plane. Measurements were repeated twice according to each line. The intra‐class coefficient was used to estimate intra‐observer and inter‐observer reliability; the Altman and Bland plot was used to assess the agreement between MRI and clinical measurements.ResultsThe intra‐observer and inter‐observer reliability of MRI measurements were in general excellent. Intra‐class coefficients were better for the mid‐pubic line than the perineal line. Although the MRI measurements correlate significantly with the physical measurements, the Altman and Bland plot shows an unacceptable magnitude of discrepancy between clinical and MRI examinations.ConclusionsAlthough dynamic MRI shows excellent inter‐ and intra‐observer reliability, its agreement with clinical examination is poor whatever the line used. Neurourol. Urodynam. 27:191–197, 2008. © 2007 Wiley‐Liss, Inc.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
JAMA network open · 2023 · Multicenter Study
Thomassin-Naggara I, Monroc M, Chauveau B, Fauconnier A, et al.
European journal of obstetrics, gynecology, and reproductive biology · 2014 · Journal Article
Pizzoferrato AC, Nyangoh Timoh K, Fritel X, Zareski E, et al.
Clinical imaging · 2013 · Journal Article
Balleyguier C, Fournet C, Ben Hassen W, Zareski E, et al.
Journal of magnetic resonance imaging : JMRI · 2011 · Journal Article
Levy A, Medjhoul A, Caramella C, Zareski E, et al.
Cancer · 2008 · Journal Article
Vincens E, Balleyguier C, Rey A, Uzan C, et al.
Neurourology and urodynamics · 2008 · Comparative Study
Fauconnier A, Zareski E, Abichedid J, Bader G, et al.
Cancers · 2022 · Journal Article
Pierre T, Selhane F, Zareski E, Garcia C, et al.
Oncotarget · 2018 · Journal Article
Sun R, Koubaa I, Limkin EJ, Dumas I, et al.
Gynecologic oncology · 2011 · Journal Article
Levy A, Caramella C, Chargari C, Medjhoul A, et al.
American journal of obstetrics and gynecology · 2008 · Journal Article
Touboul C, Fauconnier A, Zareski E, Bouhanna P, et al.